TFF Group (OTCMKTS:FRFTF) Sees Large Decline in Short Interest

TFF Group (OTCMKTS:FRFTF) was the target of a significant decline in short interest in the month of February. As of February 27th, there was short interest totaling 15,206 shares, a decline of 17.1% from the February 12th total of 18,343 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

TFF Group Stock Performance

Shares of OTCMKTS:FRFTF opened at C$20.14 on Tuesday. The business has a 50 day moving average price of C$20.30 and a 200 day moving average price of C$21.18. TFF Group has a twelve month low of C$20.14 and a twelve month high of C$20.70.

TFF Group Company Profile

TFF Group (OTCMKTS:FRFTF) is a clinical-stage specialty pharmaceutical company developing and commercializing medicines based on its proprietary thin-film drug delivery platform. The company’s core technology transforms active pharmaceutical ingredients into solid films that dissolve rapidly in the oral cavity or adhere to mucosal surfaces, enabling precise dosing without water, potential improvements in bioavailability and the opportunity to create novel dosage forms. TFF Group’s platform supports a broad range of molecules, from small-molecule drugs and peptides to vaccines and biologics.

Headquartered in Kansas City, Missouri, with research and manufacturing facilities in Europe, TFF Group applies its thin-film technology across multiple therapeutic areas, including central nervous system disorders, hormone replacement therapy, respiratory diseases and vaccines.